Company Data
SELLAS Life Sciences Group Inc.
Ticker
SLS
Current Price
$8.33 -8.16%
Market Cap
$1.5B
Price Target
Refer to Report
Volume
10.3M
52wk Range
$1.39 - $9.51
Overview
SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax.